𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor interaction with hemostasis: The rationale for the use of platelet inhibitors and anticoagulants in the treatment of cancer

✍ Scribed by Hamid Al-Mondhiry

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
717 KB
Volume
16
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Anticoagulation for the initial treatmen
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer : A systematic review
✍ Elie A. Akl; Sandeep Rohilla; Maddalena Barba; Francesca Sperati; Irene Terrenat πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 312 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. The authors compared the relative efficacy and safety of low‐ molecular‐weight heparin (LMWH) and unfractionated heparin (UFH) for the initial treatment of venous thromboembolism (VTE) between patients with and without cancer. ## METHODS. By using Cochrane methodology

Rationale for the use of genistein-conta
Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer
✍ Stephen Barnes; T. Greg Peterson; Lori Coward πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 701 KB

Pharmacologists have realized that tyrosine kinase inhibitors (TKI) have potential as anticancer agents, both in prevention and therapy protocols. Nonetheless, concern about the risk of toxicity caused by synthetic TKIs restricted their development as chemoprevention agents. However, a naturally occ